139 related articles for article (PubMed ID: 33277667)
1. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.
Busuttil RA; George J; House CM; Lade S; Mitchell C; Di Costanzo NS; Pattison S; Huang YK; Tan P; Cheong JH; Rha SY; Boussioutas A
Gastric Cancer; 2021 May; 24(3):589-601. PubMed ID: 33277667
[TBL] [Abstract][Full Text] [Related]
2. Demethylation of the
Li H; Zhao J; Sun J; Tian C; Jiang Q; Ding C; Gan Q; Shu P; Wang X; Qin J; Sun Y
Mol Cancer Res; 2021 Sep; 19(9):1454-1464. PubMed ID: 34016745
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the distance of proximal resection margin in patients who have undergone curative gastric cancer surgery.
Ohe H; Lee WY; Hong SW; Chang YG; Lee B
World J Surg Oncol; 2014 Sep; 12():296. PubMed ID: 25248556
[TBL] [Abstract][Full Text] [Related]
4. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
6. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
8. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
9. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
10. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
11. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
[TBL] [Abstract][Full Text] [Related]
12. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
13. Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma.
Nakanishi Y; Ohara M; Domen H; Shichinohe T; Hirano S; Ishizaka M
World J Surg Oncol; 2013 May; 11():98. PubMed ID: 23683476
[TBL] [Abstract][Full Text] [Related]
14. Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling.
Motoori M; Takemasa I; Yano M; Saito S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Kurokawa Y; Ueno N; Oba S; Ishii S; Monden M; Kato K
Int J Cancer; 2005 May; 114(6):963-8. PubMed ID: 15645432
[TBL] [Abstract][Full Text] [Related]
15. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of venous invasion in stage IB node-negative gastric cancer.
Araki I; Hosoda K; Yamashita K; Katada N; Sakuramoto S; Moriya H; Mieno H; Ema A; Kikuchi S; Mikami T; Watanabe M
Gastric Cancer; 2015 Apr; 18(2):297-305. PubMed ID: 24687437
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
18. SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection.
Kim YM; Kwon IG; Choi SH; Noh SH; Chun J; Youn YH; Park H; Nahm JH; Kim JH; Huh YM; Jang E
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683460
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
20. Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer.
Yamada S; Hatta W; Shimosegawa T; Takizawa K; Oyama T; Kawata N; Takahashi A; Oka S; Hoteya S; Nakagawa M; Hirano M; Esaki M; Matsuda M; Nakaya N; Gotoda T
Gastrointest Endosc; 2019 May; 89(5):950-960. PubMed ID: 30465769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]